DE3280252D1 - 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung. - Google Patents

1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.

Info

Publication number
DE3280252D1
DE3280252D1 DE8282810413T DE3280252T DE3280252D1 DE 3280252 D1 DE3280252 D1 DE 3280252D1 DE 8282810413 T DE8282810413 T DE 8282810413T DE 3280252 T DE3280252 T DE 3280252T DE 3280252 D1 DE3280252 D1 DE 3280252D1
Authority
DE
Germany
Prior art keywords
group
octahydrobenzo
quinoline derivatives
pharmaceutical effect
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8282810413T
Other languages
German (de)
English (en)
Inventor
Rene Nordmann
Trevor James Petcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE3280252D1 publication Critical patent/DE3280252D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Quinoline Compounds (AREA)
DE8282810413T 1981-10-16 1982-10-06 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung. Expired - Lifetime DE3280252D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH663181 1981-10-16
CH392782 1982-06-25

Publications (1)

Publication Number Publication Date
DE3280252D1 true DE3280252D1 (de) 1990-10-31

Family

ID=25694193

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8282810413T Expired - Lifetime DE3280252D1 (de) 1981-10-16 1982-10-06 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.
DE1995175006 Active DE19575006I2 (de) 1981-10-16 1982-10-06 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1995175006 Active DE19575006I2 (de) 1981-10-16 1982-10-06 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung

Country Status (19)

Country Link
US (1) US4565818A (en, 2012)
EP (1) EP0077754B1 (en, 2012)
JP (1) JPH02138262A (en, 2012)
AT (1) ATE56958T1 (en, 2012)
AU (1) AU558375B2 (en, 2012)
CA (1) CA1200241A (en, 2012)
CY (1) CY1736A (en, 2012)
DE (2) DE3280252D1 (en, 2012)
DK (1) DK160820C (en, 2012)
ES (3) ES516551A0 (en, 2012)
FI (1) FI78908C (en, 2012)
HK (1) HK107794A (en, 2012)
HU (1) HU190703B (en, 2012)
IE (1) IE56836B1 (en, 2012)
IL (1) IL66987A (en, 2012)
LU (1) LU88619I2 (en, 2012)
NZ (1) NZ202169A (en, 2012)
PH (1) PH22774A (en, 2012)
PT (1) PT75679A (en, 2012)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives
AT393997B (de) * 1983-06-22 1992-01-10 Heidelberger Druckmasch Ag Vorrichtung zur entnahme von bedruckten bogen fuer deren begutachtung
NL8702680A (nl) * 1986-11-21 1988-06-16 Sandoz Ag Nieuwe benzogchinolinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
WO1990000896A1 (en) * 1988-07-22 1990-02-08 Sandoz Ag USE OF BENZO(g)QUINOLINES IN TREATMENT OF NICOTINE ADDICTION
GB8829330D0 (en) * 1988-12-16 1989-02-01 Sandoz Ltd Improvements in or relating to organic compounds
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
AU4413999A (en) * 1998-07-28 2000-02-21 Warner-Lambert Company Hexahydro-naphthalenone oximes and hydrazones
US6380217B1 (en) * 1999-03-31 2002-04-30 Millennium Pharmaceuticals, Inc. Methods for controlling GGT-positive bacteria
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
US8334298B2 (en) 2005-04-29 2012-12-18 Ferring International Center S.A. Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist
US8067410B2 (en) 2008-06-27 2011-11-29 H. Lundbeck A/S Phenolic and catecholic amines and prodrugs thereof
EP2303851A1 (en) * 2008-06-27 2011-04-06 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof
CR20200225A (es) 2017-11-24 2020-07-25 H Lundbeck As Nuevos fármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
CN113727974B (zh) 2019-05-21 2025-01-07 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
CN113727979B (zh) 2019-05-21 2024-09-20 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
JP7514859B2 (ja) 2019-05-21 2024-07-11 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
WO2024153752A1 (en) * 2023-01-20 2024-07-25 Ferring B.V. Stereoselective synthesis of intermediates and synthesis of quinagolids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839338A (en) * 1968-05-09 1974-10-01 W Michne 1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO{8 g{9 QUINOLINES
US4100164A (en) * 1974-05-20 1978-07-11 Sterling Drug Inc. 2,6-Methano-3-benzazocines
US4169893A (en) * 1978-03-13 1979-10-02 Sandoz, Inc. 4-hydroxy-naphthpyridine-2(1h)-one-3-carboxylic acids and esters
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
DE3063420D1 (en) * 1979-03-26 1983-07-07 Takeda Chemical Industries Ltd Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension

Also Published As

Publication number Publication date
ES8606281A1 (es) 1986-04-16
LU88619I2 (fr) 1995-07-10
EP0077754A3 (en) 1985-05-22
FI823436A0 (fi) 1982-10-08
ES8706120A1 (es) 1987-06-01
DK457182A (da) 1983-04-17
JPH02138262A (ja) 1990-05-28
DE19575006I2 (de) 2003-01-09
FI78908B (fi) 1989-06-30
ES526492A0 (es) 1987-06-01
ATE56958T1 (de) 1990-10-15
PT75679A (en) 1982-11-01
EP0077754B1 (en) 1990-09-26
US4565818A (en) 1986-01-21
FI823436L (fi) 1983-04-17
AU558375B2 (en) 1987-01-29
FI78908C (fi) 1989-10-10
HK107794A (en) 1994-10-14
CY1736A (en) 1994-06-03
ES8405373A1 (es) 1984-06-01
AU8936782A (en) 1983-04-21
IE822500L (en) 1983-04-16
PH22774A (en) 1988-12-12
ES526493A0 (es) 1986-04-16
IL66987A (en) 1986-11-30
DK160820B (da) 1991-04-22
ES516551A0 (es) 1984-06-01
DK160820C (da) 1991-10-07
JPH059430B2 (en, 2012) 1993-02-04
EP0077754A2 (en) 1983-04-27
IL66987A0 (en) 1983-02-23
CA1200241A (en) 1986-02-04
NZ202169A (en) 1985-07-31
IE56836B1 (en) 1992-01-01
HU190703B (en) 1986-10-28

Similar Documents

Publication Publication Date Title
DE3280252D1 (de) 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.
DE69516540D1 (de) AMINO-IMIDAZO [4,5-c] CHINOLINE
IT8047919A0 (it) Nuovi derivati piperidinici dotati di proprieta' antiistaminiche antiallergiche e broncodilatatrici e procedimento per la loro preparazione
ATE88183T1 (de) Substituierte 4-(chinolin-2-yl-methoxy)phenylessigs|ure-derivate.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
NO892543D0 (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
YU48671B (sh) Novi derivati beta-fenilizoserina, njegovo dobijanje i primena
NO881545L (no) Nye pyrrolidin-2-(1,3-dikarbonyl)-derivater, samt fremgangsmaate for fremstilling derav.
ES482138A1 (es) Procedimiento para la obtencion de 1-bencil -fenil-piperidi-nas.
IT1226045B (it) Derivati tetraidrochinolici
PT69327A (fr) Procede d'isomerisation des derives de la vinyl-3 piperidine
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
FI905325A7 (fi) Menetelmä bentsyylipyrrolidiinijohdannaisten valmistamiseksi, jotka ovat aktiivisia dopamiiniagonisteina
JPS53144578A (en) Pyridyl methyl derivatives
BG44022A3 (en) Method for preparing of ester derivatives of diphenylether oximes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: QUINAGOLIDHYDROCHLORID; REGISTRATION NO/DATE: 30883.00.00, 30883.01.00, 30883.02.00; 19941123

Spc suppl protection certif: 195 75 006

Filing date: 19950315

8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: SPOTT WEINMILLER & PARTNER, 80336 MUENCHEN

V457 Spc granted

Free format text: PRODUCT NAME: QUINAGOLIDHYDROCHLORID; REGISTRATION NO/DATE: 30883.00.00, 30883.01.00, 30883.02.00; 19941123

Spc suppl protection certif: 195 75 006

Filing date: 19950315

V464 Spc expired

Free format text: PRODUCT NAME: QUINAGOLIDHYDROCHLORID; REGISTRATION NO/DATE: 30883.00.00, 30883.01.00, 30883.02.00; 19941123

Spc suppl protection certif: 195 75 006

Filing date: 19950315